Brief – Others 2026-08-13
Worth Noting
Each individual neuron may be doing the work of a small neural network, not a simple switch. Neuroscientists have vastly underestimated brain cells’ computing power A new study finds that a single neuron’s hundreds of dendritic branches can each perform independent computations simultaneously, suggesting the brain’s raw processing capacity dwarfs what textbooks have assumed for decades. The finding has implications for both neuroscience and for how researchers think about the gap between biological and artificial intelligence.
After fifty years on the market, scientists have finally worked out how metformin actually lowers blood sugar. Popular drug metformin transforms your gut into a sugar sink It turns out the drug redirects glucose absorption away from the bloodstream and toward the gut itself, a mechanism that was poorly understood despite metformin being one of the most prescribed medicines in the United States. Knowing the mechanism matters for designing better diabetes drugs and for understanding why some patients respond differently.
This year’s El Niño is arriving early and hitting harder than most, with crop failures already spreading across three continents. This Year’s El Niño Is Huge and Already Changing the World The pattern is not expected to peak until later in 2026, meaning the droughts and food-supply disruptions already underway in parts of Africa, Asia, and South America are likely to deepen before they ease. The piece is a useful early-warning snapshot of a phenomenon that will shape commodity prices, humanitarian needs, and extreme-weather frequency for the next year.
A promising anti-inflammation drug failed a major heart disease trial, shaking one of medicine’s most confident working theories. A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease For years, researchers have accumulated observational evidence linking chronic inflammation to cardiovascular disease and built drug pipelines around the idea; the failure of this Novo Nordisk compound raises the uncomfortable question of whether the inflammation-causes-heart-disease hypothesis is weaker than the field has assumed. Cardiologists and drug developers will be rethinking priorities.
World ocean temperatures broke a new July record, compounding an already extreme year for heat. World ocean temperatures hit extreme new record for July July 2026 saw the hottest ocean surface temperatures ever measured for the month, with air temperatures also running near-record highs. Warmer oceans fuel stronger hurricanes, accelerate coral bleaching, and disrupt the marine food chains that underpin global fisheries—a marker worth tracking as the Atlantic hurricane season reaches its peak weeks.
California is phasing out paraquat, a widely used herbicide with strong epidemiological links to Parkinson’s disease, even as farmers argue there is no practical substitute. This Pesticide May Be Too Dangerous to Use. Farmers Say They Need It. The move puts California ahead of most of the world in restricting a chemical that is already banned in the European Union and the UK, and it sets up a collision between agricultural economics and a growing body of neurological research.
One Thing Worth Reading Deeply
Inflammation Keeps Us Alive. It’s Also Making Us Sick.
This long-form NYT Magazine piece makes the case that chronic low-grade inflammation may be the unifying mechanism behind Alzheimer’s, cancer, diabetes, and cardiovascular disease—potentially the most consequential medical insight of the century. It arrives at exactly the moment that the failure of a major anti-inflammation heart drug (noted above) complicates the picture, making the underlying science both more important and more contested. The piece moves carefully from cellular biology through epidemiology to clinical trials, accessible to a non-specialist reader without condescending to one. Read it alongside the Novo Nordisk trial failure news for a fuller sense of where this frontier actually stands.